High-flow nasal cannula versus nasal continuous positive airway pressure in the management of respiratory distress syndrome

Journal of Isfahan Medical School

Volumn 29, Issue 143, 2011, Pages

  Iranpour, Ramin ^a   Sadeghnia, Alireza ^a   Hesaraki, Mehran ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

High flow nasal cannula; Nasal continuous positive airway pressure; Neonates; Respiratory distress syndrome

Indexed keywords

OXYGEN;

APNEA; ARTICLE; ASSISTED VENTILATION; BRAIN HEMORRHAGE; CHRONIC LUNG DISEASE; CONTROLLED STUDY; ENTERIC FEEDING; HIGH FLOW NASAL CANNULA; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE; NECROTIZING ENTEROCOLITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; RANDOMIZED CONTROLLED TRIAL; SEPSIS; TREATMENT FAILURE;

EID: 80051955924     PISSN: 10277595     EISSN: 1735854X     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Martin RJ, Fanaroff AA, Walsh MC. Neonatal- Perinatal medicine. 8th ed. Philadelphia: Mosby; 2005.
2. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2001; (2): CD000510.
3. Goldsmith JP, Karotkin E. Assisted Ventilation of the Neonate. 4th ed. Philadelphia: Saunders; 2003.
4. Zaharie G, Ion DA, Schmidt N, Popa M, Kudor-Szabadi L, Zaharie T. [Prophylactic CPAP versus therapeutic CPAP in preterm newborns of 28-32 gestational weeks]. Pneumologia 2008; 57(1): 34-7.
5. Miksch RM, Armbrust S, Pahnke J, Fusch C. Outcome of very low birthweight infants after introducing a new standard regime with the early use of nasal CPAP. Eur J Pediatr 2008; 167(8): 909-16.
6. Sandri F, Ancora G, Lanzoni A, Tagliabue P, Colnaghi M, Ventura ML, et al. Prophylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestation: multicentre randomised controlled clinical trial. Arch Dis Child Fetal Neonatal Ed 2004; 89(5): F394-F398.
7. Dani C, Bertini G, Pezzati M, Cecchi A, Caviglioli C, Rubaltelli FF. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks' gestation. Pediatrics 2004; 113(6): e560-e563.
8. Bohlin K, Gudmundsdottir T, Katz-Salamon M, Jonsson B, Blennow M. Implementation of surfactant treatment during continuous positive airway pressure. J Perinatol 2007; 27(7): 422-7.
9. Ho JJ, Henderson-Smart DJ, Davis PG. Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2002; (2): CD002975.
10. Jobe AH, Kramer BW, Moss TJ, Newnham JP, Ikegami M. Decreased indicators of lung injury with continuous positive expiratory pressure in preterm lambs. Pediatr Res 2002; 52(3): 387-92.
11. do Nascimento RM, Ferreira AL, Coutinho AC, Santos Verissimo RC. The frequency of nasal injury in newborns due to the use of continuous positive airway pressure with prongs. Rev Lat Am Enfermagem 2009; 17(4): 489-94.
12. McCoskey L. Nursing Care Guidelines for prevention of nasal breakdown in neonates receiving nasal CPAP. Adv Neonatal Care 2008; 8(2): 116-24.
13. Locke RG, Wolfson MR, Shaffer TH, Rubenstein SD, Greenspan JS. Inadvertent administration of positive end-distending pressure during nasal cannula flow. Pediatrics 1993; 91(1): 135-8.
14. Saslow JG, Aghai ZH, Nakhla TA, Hart JJ, Lawrysh R, Stahl GE, et al. Work of breathing using high-flow nasal cannula in preterm infants. J Perinatol 2006; 26(8): 476-80.
15. US Food and Drug Administration [Online] 2007 Aug 10. Available from:URL:http.www.fda.gov/cdrh/pdf4/k042245.pdf.
16. Shoemaker MT, Pierce MR, Yoder BA, DiGeronimo RJ. High flow nasal cannula versus nasal CPAP for neonatal respiratory disease: a retrospective study. J Perinatol 2007; 27(2): 85-91.
17. Sun S, Tero R. Safety and efficacy of the Vapotherm 20001 in the neonatal population. Proceeding of the: AARC International Respiratory Congress; 2004 Dec 4-7; New Orleans, USA.
18. Ramanathan A, Cayabyab R, Sardesai S, Siassi B, Seri I, Ramanathan R. High flow nasal cannula use in preterm and term newborns admitted to neonatal intensive care unit: A prospective, observational study. Pediatr Acad Soc 2005; 57(3424).
19. Sreenan C, Lemke RP, Hudson-Mason A, Osiovich H. High-flow nasal cannulae in the management of apnea of prematurity: a comparison with conventional nasal continuous positive airway pressure. Pediatrics 2001; 107(5): 1081-3.
20. Campbell DM, Shah PS, Shah V, Kelly EN. Nasal continuous positive airway pressure from high flow cannula versus Infant Flow for Preterm infants. J Perinatol 2006; 26(9): 546-9.
21. Update: Public health notification regarding Ralstonia associated with Vapotherm respiratory gas administration devices- United States, 2005. MMWR Morb Mortal wkly Rep 2005; 54(1286): 1287.
22. Vapotherm website [Online].2007 August 10. Available: from URL: www.vtherm.com/products/200i.asp.